Article

RET mutation as a putative prognostic biomarker for immune checkpoint inhibitors therapy in various malignancies

2023-05-31

Abstract excerpt

<h4>Background: </h4> The RET gene, which is frequently mutated across many types of cancer, has been proven to be critically involved in tumorigenesis and tumor development, while its precise contribution to immune checkpoint inhibitors (ICIs) therapy remains to be elucidated. The present research aims to investigate the association between RET mutations and the efficiency of ICIs therapy. <h4>Method: </h4> We an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1b8e0c89-4fcc-57a9-9909-8ec9dbfac6cd
DOI: 10.21203/rs.3.rs-2992541/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

RET mutation as a putative prognostic biomarker for immune checkpoint inhibitors therapy in various malignanciesDOI 10.21203/rs.3.rs-2992541/v1Read

Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts.Semantic proximity Read

Mutation of rearranged during transfection (RET) is associated with enhanced tumor immunogenicity and favorable outcomes in pan-cancer immunotherapy.Semantic proximity Read

RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesSemantic proximity Read

RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer.Semantic proximity Read

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.Semantic proximity Read

BRAF mutation predicts survival after immunotherapy across multiple cancer types.Semantic proximity Read

65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicineSemantic proximity Read

KMT2A/C mutations function as a potential predictive biomarker for immunotherapy in solid tumorsSemantic proximity Read

REToma: a cancer subtype with a shared driver oncogene.Semantic proximity Read

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatmentSemantic proximity Read

A comprehensive overview of the relationship between RET gene and tumor occurrenceSemantic proximity Read

Targeting RET alterations in cancer: Recent progress and future directions.Semantic proximity Read